Congratulations to Dr James McIlroy, Class of ‘11 and Founder and CEO of EnteroBiotix who featured in the Forbes 30 Under 30 Europe List 2022.

This year’s list focused on young Europeans who, in the face of seemingly insurmountable challenges, persevered and innovated. Dr James McIlroy is a qualified medical doctor and biopharmaceutical entrepreneur who is widely recognised as a pioneer and thought leader in the application of the microbiome to treat disease.

James commented: “I was really excited to feature on the front of Forbes Europe as one of the 30 under 30 list 2022. I am grateful to the entire EnteroBiotix team (past and present), our investors, my mentors and everyone else that has helped me along the way on the journey so far. Onwards now to the next goal and towards our vision to develop and deliver best-in-class microbiome therapies for patients all over the world.”

He founded EnteroBiotix with the vision of building one of the world’s leading microbiome drug development companies that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome.